... N.J. (AP) -- A new type of osteoporosis drug being developed by Merck & Co. increased bone density over two years in postmenopausal women with mild osteoporosis, the company reported Tuesday.... ...
BOSTON (Reuters) - Merck's popular osteoporosis drug Fosamax and other similar drugs may carry a risk for esophageal cancer, a Food and Drug Administration official said on Wednesday.
Amgen said Tuesday its experimental osteoporosis drug reduced and delayed serious bone complications among patients with advanced breast cancer.
An osteoporosis drug proven to save lives after hip fractures may do so by strengthening the body's ... impairment did not receive a mortality benefit from the drug.
It still remains unclear what role ...
... have been increasing reports of osteonecrosis (bone death) of the jaw in patients who have been taking the drugs for osteoporosis or for treatment from the bone-wasting effects of cancer. He said he ...
... risk factors for atrial fibrillation, clinicians should be more cautious when choosing treatment for osteoporosis and weigh the risks against the benefit of decreased fracture risk," said Dr. Miranda ...
... even short-term use of common oral osteoporosis drugs may leave the jaw vulnerable to devastating ... Journal of the American Dental Association (JADA). Osteoporosis currently affects 10 million Americans ...
... research.
Given these results, physicians should not change they way they prescribe the drugs for the majority of patients with osteoporosis, Singh said, and patients should not stop taking them. He ...
New research evaluated the link between a common class of drugs used to prevent bone fractures in osteoporosis patients and the development of irregular heartbeat.
The new drug, the company’s best hope for future growth, won a partial endorsement from a federal advisory committee despite concerns about the product’s safety.
... surrounding
its use are too stringent, doctors warn.
The majority of patients who are diagnosed with osteoporosis,
which causes the bones to become dangerously brittle in old age,
are prescribed a ...
... can cause bone loss. A new study has found that bone loss can be halted with a comprehensive regimen that includes both osteoporosis drugs and treatments that target secondary causes of bone loss.
Women who have used fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according to new ...
... bone growth, a finding that could lead to new osteoporosis drugs and better bone-building therapies, ... osteoclasts by resorbing old and brittle bone.
Many osteoporosis drugs now target both osteoblasts ...
... , 71, of Elmhurst, Il., learned she had osteoporosis while being treated by Albain for breast cancer. ... calcium supplements, prescription vitamin D and the osteoporosis drug Boniva. Three years after O' ...
